Other studies identified pathologic production of TNF in ET, PV, and sAML, as well as in de novo AML, implying non-JAK/STAT signaling hyperactivations almost certainly occur across the spectrum of MPNs (33, 41, 53, 82). Here, TNF is linked to acute myeloid leukemia.